Literature DB >> 11425459

Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia.

J I Martín-Subero1, L Harder, S Gesk, R Schoch, F J Novo, W Grote, M J Calasanz, B Schlegelberger, R Siebert.   

Abstract

A patient is described with myelodysplastic syndrome (MDS) progressing to acute myeloid leukemia (AML) FAB M4. Cytogenetic analysis revealed an unusual rearrangement between chromosomes 9 and 17, leading to a dicentric chromosome with an insertion of material of unknown origin between both chromosomes. By fluorescence in situ hybridization (FISH), the insertion was shown to be an amplification of part of 17q, involving ERBB2, RARA, and TOP2A genes. The median copy number of ERBB2, RARA, and TOP2A genes in the tumor cells was six (range: 4--10). Only one copy of the MPO gene at 17q21.3 was detected, suggesting a deletion of the telomeric part of 17q. To our knowledge, this is the first report of a 17q amplification in AML.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11425459     DOI: 10.1016/s0165-4608(00)00431-3

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  miR-125a regulates cell cycle, proliferation, and apoptosis by targeting the ErbB pathway in acute myeloid leukemia.

Authors:  Melanie L Ufkin; Sarah Peterson; Xuehui Yang; Heather Driscoll; Christine Duarte; Pradeep Sathyanarayana
Journal:  Leuk Res       Date:  2014-01-08       Impact factor: 3.156

2.  Feature genes predicting the FLT3/ITD mutation in acute myeloid leukemia.

Authors:  Chenglong Li; Biao Zhu; Jiao Chen; Xiaobing Huang
Journal:  Mol Med Rep       Date:  2016-05-12       Impact factor: 2.952

3.  Detection of deregulated modules using deregulatory linked path.

Authors:  Yuxuan Hu; Lin Gao; Kai Shi; David K Y Chiu
Journal:  PLoS One       Date:  2013-07-24       Impact factor: 3.240

4.  The HER2 inhibitor TAK165 Sensitizes Human Acute Myeloid Leukemia Cells to Retinoic Acid-Induced Myeloid Differentiation by activating MEK/ERK mediated RARα/STAT1 axis.

Authors:  Xuejing Shao; Yujia Liu; Yangling Li; Miao Xian; Qian Zhou; Bo Yang; Meidan Ying; Qiaojun He
Journal:  Sci Rep       Date:  2016-04-14       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.